<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tissue plasminogen activator (tPA) dissolves intravascular <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> and restores blood flow after thromboembolic <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The utility of this agent for treatment of <z:hpo ids='HP_0001297'>stroke</z:hpo> in humans may be limited by post-reperfusion hemorrhagic complications </plain></SENT>
<SENT sid="2" pm="."><plain>We studied tPA-mediated thrombolysis in an animal model of <z:e sem="disease" ids="C0596298" disease_type="Disease or Syndrome" abbrv="">cerebrovascular occlusion</z:e> in order to determine what factors, if any, predispose tPA-treated animals to suffer <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Small blood clot emboli were injected into the internal carotid arteries of rabbits </plain></SENT>
<SENT sid="4" pm="."><plain>Angiograms confirmed occlusion of the middle cerebral artery or internal carotid artery in 100% of subjects </plain></SENT>
<SENT sid="5" pm="."><plain>tPA or saline was administered as a 30-minute infusion at various times after embolization </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0001914'>Hemorrhage</z:mp> rates were similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups regardless of treatment </plain></SENT>
<SENT sid="7" pm="."><plain>tPA increased the prothrombin time and the thrombin time but not the partial thromboplastin time </plain></SENT>
<SENT sid="8" pm="."><plain>There was no correlation between these changes in blood coagulation and the finding of <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>We observed a significant association between <z:hpo ids='HP_0001297'>stroke</z:hpo> severity and <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that tPA treatment successfully causes thrombolysis of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral emboli</z:e> without causing an increase in the incidence of <z:hpo ids='HP_0001342'>cerebral hemorrhage</z:hpo> in rabbits </plain></SENT>
</text></document>